Gonadotropin-releasing hormone antagonist linzagolix: possible treatment for assisted reproduction patients presenting with adenomyosis and endometriosis?
This paper explores the potential of gonadotropin-releasing hormone antagonist linzagolix as a treatment option for patients undergoing assisted reproduction who also present with adenomyosis and endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (5)
- Adenomyosis does not affect implantation, but is associated with miscarriage in patients undergoing oocyte donation via openalex
- Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis via openalex
- Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis via openalex
- Single-cell RNA sequencing of oocytes from ovarian endometriosis patients reveals a differential transcriptomic profile associated with lower quality via openalex
- Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis via openalex
Cited by (12)
- Role of oral gonadotropin-releasing hormone antagonists in the management of uterine adenomyosis: a narrative review 2026
- Compromised concept: Link between endometriosis, pregnancy complications and infertility 2025
- The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis 2023
- Medical treatment of adenomyosis: a literature review 2023
- Changes in adenomyosis following elagolix vs leuprolide treatment in a patient with pelvic pain and infertility: A case report 2023
- Gynecological uses of GnRH antagonists: review article 2022
- Nonsurgical management of adenomyosis: an overview of current evidence 2022
- Conservative surgical and drug therapies for adenomyosis Medicine 2022
- Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New 'Hit Hard First and then Maintain' Regimen of Administration 2021
- Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review 2021
- Adenomyosis: Impact on Fertility and Obstetric Outcomes 2021
- Medical Treatment for Endometriosis: Tolerability, Quality of Life and Adherence 2021
Source provenance
- europepmc
- last seen: 2026-10-21T06:16:17.486033+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:28:11.599399+00:00
- unpaywall
- last seen: 2026-09-17T06:32:46.214484+00:00